Harvard Bioscience, Inc. (HBIO) Stock Overview
Explore Harvard Bioscience, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Harvard Bioscience, Inc. (HBIO)
Key Financials
Key Financials
Market Cap
33.7M
P/E Ratio
-3.19
EPS (TTM)
$-0.36
ROE
-0.92%
HBIO Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of Harvard Bioscience, Inc. (NASDAQ: HBIO) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Harvard Bioscience, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of HBIO on the NASDAQ shows an RSI of 69.59, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $3.70 for the NASDAQ listing.
Key metrics behind Harvard Bioscience, Inc.'s NASDAQ-traded stock include a P/E ratio of -3.19 and a market capitalization of 33.7M. Combined with our AI analysis, these give both institutional and retail investors a clear view of HBIO on the NASDAQ.